Epilepsy Monitoring Devices

Feb 09, 2026

Summary Drug-resistant epilepsy affects 20-40% of epilepsy patients in the US, rising to 30-40% in adults versus 7-20% in children, with similar rates (over 25%) in Europe; about one-quarter of newly diagnosed cases progress to DRE. Vagus Nerve Stimulation (VNS Therapy by LivaNova) is FDA-approved for drug-r...

Dec 03, 2025

Epilepsy affects nearly 50 million people globally, making it one of the most common neurological disorders, with about 80% of cases occurring in low- and middle-income countries where diagnostic and treatment resources are limited. Yet with timely and appropriate care, up to 70% of individuals with epilepsy can be...